Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment.

ABSTRACT: BACKGROUND:Our preliminary data showed a slight decrease of estimated glomerular filtration rate (eGFR) after direct-acting antivirals (DAAs) treatment in chronic hepatitis C (CHC). However, long-term outcome of renal evolution after DAAs has not been well documented. AIM:To assess the renal function under DAAs treatment in CHC patients of an Asian population at 6 months and 1 year after complete treatment. METHODS:A cohort of 1536 CHC patients who received therapies with DAAs were analyzed. Serial eGFR levels at 24 weeks after treatment (SVR24) and 48 weeks after treatment (SVR48) were evaluated. We compared eGFR at baseline, SVR12, SVR24 and SVR48, and defined renal function deterioration as decrease of eGFR >25% from baseline to SVR24 and SVR48. RESULTS:Overall, there was decline of eGF

SUBMITTER: Chiu SM 

PROVIDER: S-EPMC7156075 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature